4.7 Article

Functional TCR T cell screening using single-cell droplet microfluidics

期刊

LAB ON A CHIP
卷 18, 期 24, 页码 3733-3749

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c8lc00818c

关键词

-

资金

  1. NIH [1DP2CA195763, R21CA219225]
  2. Amberstone Biosciences LLC [AB-208317]
  3. NATIONAL CANCER INSTITUTE [R21CA219225, DP2CA195763] Funding Source: NIH RePORTER
  4. NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Adoptive T cell transfer, in particular TCR T cell therapy, holds great promise for cancer immunotherapy with encouraging clinical results. However, finding the right TCR T cell clone is a tedious, time-consuming, and costly process. Thus, there is a critical need for single cell technologies to conduct fast and multiplexed functional analyses followed by recovery of the clone of interest. Here, we use droplet microfluidics for functional screening and real-time monitoring of single TCR T cell activation upon recognition of target tumor cells. Notably, our platform includes a tracking system for each clone as well as a sorting procedure with 100% specificity validated by downstream single cell reverse-transcription PCR and sequencing of TCR chains. Our TCR screening prototype will facilitate immunotherapeutic screening and development of T cell therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据